Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Innovate Biopharmaceuticals Inc.

www.innovatebiopharma.com

Latest From Innovate Biopharmaceuticals Inc.

Takeda Acquires Celiac Venture PvP For Up To $330m

Japanese firm exercises option after promising Phase I results in disorder with no approved drugs, in deal that builds out its celiac pipeline.

Japan Business Strategies

Takeda Adds Celiac Disease Candidate To GI Efforts

Takeda has exercised an option on partner Cour Pharmaceutical’s first-in-class lead product, after a positive Phase IIa study showed, for the first time, it was possible to induce specific immune tolerance to a foreign antigen in an autoimmune disease.

Deals Gastrointestinal

Tech Transfer Roundup: Mustang Licenses St. Jude’s Gene Therapy For Bubble Boy Disease

Fortress Biotech’s subsidiary will add the lentiviral gene therapy now in pair of Phase I/II trials to its pipeline. RXi partners with Karolinska to advance its self-delivering RNAi technology, while Avalon enlists Weill Cornell to enhance its CAR-T capabilities.

Deals Intellectual Property

Start-Up Quarterly Statistics: Fundraising Fell, But Deal-Making Rose In Q3

A review of biopharma start-up deal-making and financing activity from July through September 2017, based on data from Strategic Transactions, showed that fundraising declined 18% from the previous quarter, however the number of acquisitions doubled to eight.

StartUps and SMEs Financing
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • MRI, NMR
  • Pharmaceuticals
  • Therapeutic Areas
  • Gastrointestinal
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Innovate Biopharmaceuticals Inc.
  • Senior Management
  • Sandeep Laumas, MD, CEO
    Ed Sitar, CFO
    June Almenoff, MD, PhD, COO & CMO
    Jay P Madan, VP, Corp. Dev.
    Patrick Griffin, MD, CMO
  • Contact Info
  • Innovate Biopharmaceuticals Inc.
    Phone: (919) 275-1933
    8480 Honeycutt Rd., Ste. 200
    Raleigh, NC 27615
    USA
UsernamePublicRestriction

Register